Vera  Hirsh



McGill University Health Centre
Cedars Cancer Centre
1001 Decarie Boulevard
Montreal, Quebec H4A 3J1

Telephone: (514) 934-1934 X 35997

Education: M.D., Universitas Carolina Pragensis, Charles University

Clinical Focus: Lung cancer

Recent Presentations:

Management of Adverse Events and Quality of Life on LUX LUNG Trials. Nordic Oncology Group Meeting, Copenhagen, Denmark, January 17, 2014

Bone Metastases in NSCLC - Bisphosphonates and Beyond.The European Lung Cancer Conference (ELCC), organized by ESMO/IASLC, Geneva, Switzerland, March 29, 2014

Quality of Life Results and Management of Side Effects in Afatinib-Treated Patients with Advanced NSCLC. Moscow Cancer Congress, Moscow, Russia, April 20, 2014

First-Line Treatment of Metastatic NSCLC. Italian Conference Tour, Rome, Milan, Bologna, and Padua, Italy, June 16-20, 2014.

Phase III Trials with Lung Cancer Vaccines. Latin America Lung Cancer Conference (LALCA), Lima, Peru, South America, August 22, 2014

Patient Quality of Life and Patient Reported Outcomes (Lux Lung 3 and 6). Austrian Lung Cancer Symposium, Vienna, Austria, September 19, 2014

Bisphosphonates vs Rank Ligand Inhibition in Bone Metastases. Perspectives in Thoracic Oncology Annual Conference, New York City, NY, USA, November 22, 2014

Recent Publications:

Please click here for Dr. Vera Hirsh’s complete publication list.